DeepInfra | $107,000,000 | (May 5, 2026)
Kibu, Inc | $10,500,000 | (May 5, 2026)
Fun | $72,000,000 | (May 5, 2026)
Certified by Founder
Lodge
Oryon Cell Therapies
start up
United States
- Belmont, Massachusetts
- 24/03/2026
- Series A
- $21,000,000
Oryon Cell Therapies is a clinical-stage biotechnology company developing autologous cell therapies for neurodegenerative disorders, with an initial focus on Parkinson’s disease. Co-founded in 2020 by Ole Isacson, M.D. Ph.D., and Nikola Kojic, M.D., Ph.D., the company’s technology is designed to restore synaptic function and motor control by replacing neurons lost to the disease, with the goal of achieving functional restoration.
- Industry Biotechnology Research
- Website https://oryoncelltherapies.com/
- LinkedIn https://www.linkedin.com/company/oryon-cell-therapies/
![Allison [Techstars Miami 2022]](/uploads/i6uA3MA4h0T9vFt1686038320.png)
Panthalassa | $140,000,000 | (May 5, 2026)
Featherless AI | $20,000,000 | (May 5, 2026)
Healthfab | $2,100,000 | (May 5, 2026)
LakeFusion | $7,500,000 | (May 5, 2026)
Enzo Health | $20,000,000 | (May 5, 2026)
Barocal | $10,000,000 | (May 5, 2026)
Zapdos Labs | $500,000 | (May 5, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)